Generic Penetration in the Retail Atypical Antipsychotic Market

| March 31, 2010 | 0 Comments

by Susan Lenderts, BA; Amir H. Kalali, MD; and Peter Buckley, MD
Ms. Lenderts is Manager, Strategic Analytics, Quintiles Commercial, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles, Inc., and Professor of Psychiatry, University of California, San Diego, California. Dr. Buckley is Professor and Chairman, Department of Psychiatry, Medical College of Georgia, Augusta, Georgia.

Psychiatry (Edgemont) 2010;7(3):9–10

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , , , , ,

Category: Past Articles, Psychiatry, Psychopharmacology, Schizophrenia, Trend Watch

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.